These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 32443883)

  • 21. Antiparasitic chemotherapy: tinkering with the purine salvage pathway.
    Datta AK; Datta R; Sen B
    Adv Exp Med Biol; 2008; 625():116-32. PubMed ID: 18365663
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Discovery of novel hit compounds with broad activity against visceral and cutaneous Leishmania species by comparative phenotypic screening.
    Lamotte S; Aulner N; Späth GF; Prina E
    Sci Rep; 2019 Jan; 9(1):438. PubMed ID: 30679614
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Presentation of the protective parasite antigen LACK by Leishmania-infected macrophages.
    Prina E; Lang T; Glaichenhaus N; Antoine JC
    J Immunol; 1996 Jun; 156(11):4318-27. PubMed ID: 8666803
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A nanotechnology based new approach for chemotherapy of Cutaneous Leishmaniasis: TIO2@AG nanoparticles - Nigella sativa oil combinations.
    Abamor ES; Allahverdiyev AM
    Exp Parasitol; 2016 Jul; 166():150-63. PubMed ID: 27109311
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anti-Leishmania activity of new ruthenium(II) complexes: Effect on parasite-host interaction.
    Costa MS; Gonçalves YG; Nunes DCO; Napolitano DR; Maia PIS; Rodrigues RS; Rodrigues VM; Von Poelhsitz G; Yoneyama KAG
    J Inorg Biochem; 2017 Oct; 175():225-231. PubMed ID: 28783554
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Quantitative proteomic profiling of the promastigotes and the intracellular amastigotes of Leishmania donovani isolates identifies novel proteins having a role in Leishmania differentiation and intracellular survival.
    Biyani N; Madhubala R
    Biochim Biophys Acta; 2012 Dec; 1824(12):1342-50. PubMed ID: 22850196
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Novel organic salts based on quinoline derivatives: The in vitro activity trigger apoptosis inhibiting autophagy in Leishmania spp.
    Calixto SL; Glanzmann N; Xavier Silveira MM; da Trindade Granato J; Gorza Scopel KK; Torres de Aguiar T; DaMatta RA; Macedo GC; da Silva AD; Coimbra ES
    Chem Biol Interact; 2018 Sep; 293():141-151. PubMed ID: 30098941
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterization of developmentally-regulated activities in axenic amastigotes of Leishmania donovani.
    Saar Y; Ransford A; Waldman E; Mazareb S; Amin-Spector S; Plumblee J; Turco SJ; Zilberstein D
    Mol Biochem Parasitol; 1998 Sep; 95(1):9-20. PubMed ID: 9763285
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Stage-specific activity of pentavalent antimony against Leishmania donovani axenic amastigotes.
    Ephros M; Bitnun A; Shaked P; Waldman E; Zilberstein D
    Antimicrob Agents Chemother; 1999 Feb; 43(2):278-82. PubMed ID: 9925518
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Quantitative proteomic analysis of amastigotes from Leishmania (L.) amazonensis LV79 and PH8 strains reveals molecular traits associated with the virulence phenotype.
    de Rezende E; Kawahara R; Peña MS; Palmisano G; Stolf BS
    PLoS Negl Trop Dis; 2017 Nov; 11(11):e0006090. PubMed ID: 29176891
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cloning and expression of a Leishmania donovani gene instructed by a peptide isolated from major histocompatibility complex class II molecules of infected macrophages.
    Campos-Neto A; Soong L; Cordova JL; Sant'Angelo D; Skeiky YA; Ruddle NH; Reed SG; Janeway C; McMahon-Pratt D
    J Exp Med; 1995 Nov; 182(5):1423-33. PubMed ID: 7595213
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vitro and in vivo antileishmanial activity of a fluoroquinoline derivate against Leishmania infantum and Leishmania amazonensis species.
    Tavares GSV; Mendonça DVC; Lage DP; Antinarelli LMR; Soyer TG; Senna AJS; Matos GF; Dias DS; Ribeiro PAF; Batista JPT; Poletto JM; Brandão GC; Chávez-Fumagalli MA; Pereira GR; Coimbra ES; Coelho EAF
    Acta Trop; 2019 Mar; 191():29-37. PubMed ID: 30586571
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Leishmania donovani development in Phlebotomus argentipes: comparison of promastigote- and amastigote-initiated infections.
    Sadlova J; Myskova J; Lestinova T; Votypka J; Yeo M; Volf P
    Parasitology; 2017 Apr; 144(4):403-410. PubMed ID: 27876097
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of sodium stibogluconate and pentamidine on in vitro multiplication of Leishmania donovani in peritoneal macrophages from infected and drug-treated BALB/c mice.
    Sodhi S; Kaur S; Mahajan RC; Ganguly NK; Malla N
    Immunol Cell Biol; 1992 Feb; 70 ( Pt 1)():25-31. PubMed ID: 1322361
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Miransertib (ARQ 092), an orally-available, selective Akt inhibitor is effective against Leishmania.
    Nandan D; Zhang N; Yu Y; Schwartz B; Chen S; Kima PE; Reiner NE
    PLoS One; 2018; 13(11):e0206920. PubMed ID: 30399177
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Transgenic Leishmania donovani clinical isolates expressing green fluorescent protein constitutively for rapid and reliable ex vivo drug screening.
    Singh N; Gupta R; Jaiswal AK; Sundar S; Dube A
    J Antimicrob Chemother; 2009 Aug; 64(2):370-4. PubMed ID: 19525291
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tannins and related compounds: killing of amastigotes of Leishmania donovani and release of nitric oxide and tumour necrosis factor alpha in macrophages in vitro.
    Kiderlen AF; Kayser O; Ferreira D; Kolodziej H
    Z Naturforsch C J Biosci; 2001; 56(5-6):444-54. PubMed ID: 11421463
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The antifungal compound butenafine eliminates promastigote and amastigote forms of Leishmania (Leishmania) amazonensis and Leishmania (Viannia) braziliensis.
    Bezerra-Souza A; Yamamoto ES; Laurenti MD; Ribeiro SP; Passero LF
    Parasitol Int; 2016 Dec; 65(6 Pt A):702-707. PubMed ID: 27546158
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacies of vesicular and free sodium stibogluconate formulations against clinical isolates of Leishmania donovani.
    Carter KC; Mullen AB; Sundar S; Kenney RT
    Antimicrob Agents Chemother; 2001 Dec; 45(12):3555-9. PubMed ID: 11709339
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characterization of Transplasma Membrane Electron Transport Chain in Wild and Drug-Resistant Leishmania donovani Promastigote and Amastigote.
    Debnath D; Hossain MA; Das M; Kabir A; Ibrahim M; Amin MN; Chowdhury A; Pervin R
    Acta Parasitol; 2019 Dec; 64(4):710-719. PubMed ID: 30941668
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.